You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ):目前公司國際營銷團隊正持續與多個意向國家接觸
格隆匯 05-11 19:09

格隆匯5月11日丨沃森生物(300142.SZ)於2023年5月9日、5月10日舉行路演活動,問答環節中,就“公司未來的國際化規劃是怎樣的?近期有新增產品出口嗎?”,公司回覆稱,公司國際市場的開拓重心是東南亞、中東及北非、南美等人口增長快、體量較大的國家和地區,這些國家財政情況相對良好,本身疫苗市場需求較大,並且部分國家希望引入先進企業,以分包裝為切入點逐步打造本土疫苗產業。目前,公司國際營銷團隊正在持續與多個意向國家接觸,同步開展目標國家的註冊准入工作,年內已實現13價肺炎結合疫苗在孟加拉國、流腦四價多糖疫苗在巴基斯坦的註冊,正在爭取其他國家的註冊,不斷加快公司產品的海外佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account